Intra-articular Injection: A Innovational Approach for Joint Disorder

Launched by MUHAMMAD · Mar 4, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment called Intra-articular Injection to see if it can help people with Temporomandibular Joint Dysfunction (TMD), which affects the jaw joint and can cause pain and discomfort. The researchers want to find out if this injection can improve symptoms for those who have this condition. Participants will be divided into two groups: one will receive the injection along with standard treatment, while the other will get only the standard treatment. The study will last for 15 days, and researchers will compare how both groups feel to determine the effectiveness of the injection.

To be eligible for this trial, participants should be between the ages of 65 to 74 and must have clear symptoms of TMD, confirmed by a doctor and X-ray. It’s important that participants are mentally capable of understanding the study and willingly agree to take part. However, those with certain serious health issues, recent joint treatments, or specific infections will not be able to join. If you or a loved one is experiencing significant jaw pain and meets these criteria, this trial could offer a chance to explore a potential new treatment option.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Presence of significant temporomandibular disorder clinical symptoms.
• • Meeting the diagnostic criteria for Temporomandibular Joint Dysfunction and confirmed by X-ray examination.
• • Patients voluntarily participate in this study and provide signed informed consent.
• • Normal cognitive function
• Exclusion Criteria:
• • Rheumatic, rheumatoid, or other severe systemic diseases.
• • Infectious temporomandibular joint arthritis or joint tumors.
• • Individuals who have recently received joint injection treatment or photodynamic therapy.